Federation Des Caisses Desjardins Du Quebec Opiant Pharmaceuticals, Inc. Transaction History

Federation Des Caisses Desjardins Du Quebec

$17.5 Billion
Q2 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Aug 14, 2024	SELL	$0.0 - $21.1 $0 - $3,798	-180 Closed	0 $0
Q1 2022 Aug 14, 2024	BUY	$19.54 - $33.59 $3,517 - $6,046	180 New	180 $3.86 Million
Q3 2021 Aug 30, 2024	SELL	$13.28 - $25.79 $5,312 - $10,316	-400 Reduced 68.97%	180 $4.63 Million
Q2 2021 Aug 30, 2024	BUY	$10.5 - $14.19 $6,090 - $8,230	580 New	580 $7.76 Million
Q4 2018 Aug 30, 2024	BUY	$13.84 - $18.79 $12,871 - $17,474	930 New	930 $13.4 Million
Q3 2018 Aug 30, 2024	BUY	$12.89 - $23.43 $4,511 - $8,200	350 Added 60.34%	930 $16.6 Million
Q1 2018 Aug 30, 2024	BUY	$18.8 - $26.5 $10,904 - $15,370	580 New	580 $11.1 Million

Others Institutions Holding OPNT

# of Institutions

Shares Held

300

Call Options Held

Put Options Held

View Full List

About OPIANT PHARMACEUTICALS, INC.

Ticker OPNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,164,150
Description
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...

More about OPNT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account